Exploring Host-driven Immunopathological Factors Developing Severe Tuberculosis: Insights from Comparative Mouse
Hongmin Kim1, Kee Woong Kwon1,2, Hagyu Kim3
1Department of Microbiology, Institute for Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul, South Korea.
International Journal of Biological Sciences
|March 9, 2026
Summary
Host immune responses and Mycobacterium tuberculosis (Mtb) genetic diversity drive tuberculosis (TB) pathogenesis. This study identifies the neutrophil-to-T cell ratio and granulocyte-monocyte progenitor expansion as key drivers of TB immunopathology, offering new therapeutic targets.
Area of Science:
- Immunology
- Infectious Diseases
- Genetics
Background:
- Tuberculosis (TB) pathogenesis involves complex host immune responses and Mycobacterium tuberculosis (Mtb) genetic diversity.
- Understanding host determinants of TB immunopathology is crucial for developing effective treatments.
Purpose of the Study:
- To investigate host factors contributing to TB immunopathology using a comparative analysis of inbred mouse strains infected with Mtb.
- To identify key cellular and molecular mechanisms driving TB severity and pathology.
Main Methods:
- Comparative analysis of inbred mouse strains (C3H/HeJ, A/J, C57BL/6) infected with virulent Mtb K strain.
- Assessment of pulmonary bacterial burden, lung pathology, immune cell infiltration (neutrophils, T cells), and progenitor cell populations (GMPs).
- Intervention studies including neutrophil depletion, type I IFN blockade, IL-10 receptor blockade, and BCG vaccination.
Main Results:
- C3H/HeJ and A/J mice showed increased susceptibility to TB, with higher bacterial loads and lung pathology.
- Increased disease severity correlated with neutrophilic infiltration, elevated G-CSF, bone marrow GMP expansion, and a high pulmonary neutrophil-to-T cell (N/T) ratio.
- Neutrophil depletion and type I IFN blockade significantly reduced disease severity.
- Strain-specific interventions (IL-10R blockade, aging, BCG vaccination) modulated disease severity by restoring N/T ratios and normalizing GMP levels.
Conclusions:
- The pulmonary N/T ratio and GMP expansion are central drivers of TB immunopathology, linked to type I IFN signaling and neutrophil-mediated inflammation.
- Targeting neutrophil recruitment and type I IFN signaling may ameliorate TB severity.
- Host genetic background influences susceptibility and response to interventions, highlighting the need for personalized approaches in TB treatment.


